Animal Models of T Cell-Mediated Skin Diseases
Pharmaceutical companies are spending increasing amounts of money on drug discovery and development. Nevertheless, attrition rates in clinical development are still very high, and up to 90% of new compounds fail in clinical phase I - III trials, which is partially due to lack of clinical efficacy. T...
Cote: | Libro Electrónico |
---|---|
Collectivité auteur: | |
Autres auteurs: | , , |
Format: | Électronique eBook |
Langue: | Inglés |
Publié: |
Berlin, Heidelberg :
Springer Berlin Heidelberg : Imprint: Springer,
2005.
|
Édition: | 1st ed. 2005. |
Collection: | Ernst Schering Foundation Symposium Proceedings ;
50 |
Sujets: | |
Accès en ligne: | Texto Completo |